Literature DB >> 1526862

Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery: definite but limited influence on relapse-free survival and survival.

M L Lybeert1, H Martijn, W de Neve, M A Crommelin, J G Ribot.   

Abstract

A group of 95 patients, treated with irradiation for relapse after radical surgery as only initial treatment modality for a rectal carcinoma was studied. The term locoregional relapse relates to evidence of tumor recurrent in the pelvis or the perineal area. Seventy-six patients presented with locoregional relapse only, and 19 patients presented with locoregional relapse and concomitant distant metastases. All patients were irradiated at the site of locoregional relapse. Total dose of irradiation was resp. 44 Gy median (range 6-66 Gy) and 40 Gy median (range 6-50 Gy). In the group of patients with locoregional relapse only, recurrence-free survival and survival after radiotherapy were, respectively, 23% and 61% at 1 year, and 6% and 13% at 3 years. In the group of patients with concomitant distant metastases, survival after radiotherapy was even worse, 33% at one year, and nihil at 3 years. Recurrences after radiotherapy occurred early during follow-up with 75% of the recurrences being recorded during the first year of follow-up. Recurrent or persistent disease inside the irradiation volume was the most important clinical problem in both groups, being documented in, respectively, 43/76 and 7/19 (7/13 if six patients were excluded with a survival of less than 3 months from onset of therapy). In the group of patients with locoregional relapse only, using recurrence-free survival as the endpoint, dose of irradiation (p = 0.01) was a significant multivariate prognostic factor and using survival as the endpoint, dose of irradiation (p = 0.005) and grade of tumor differentiation (p = 0.002) were significant. Potentials of current radiotherapy regimes are limited. Therefore, maximal initial treatment is warranted. In the event of a relapse after initial radical surgery, one should opt for either more aggressive standard therapy, or either new combined modalities approaches should be studied.

Entities:  

Mesh:

Year:  1992        PMID: 1526862     DOI: 10.1016/0360-3016(92)90678-b

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Palliative treatment of rectal cancer: is radiotherapy alone a good option?

Authors:  Christopher G Willett; Leonard L Gunderson
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

Review 2.  National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States.

Authors:  Arnold Pompos; Robert L Foote; Albert C Koong; Quynh Thu Le; Radhe Mohan; Harald Paganetti; Hak Choy
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

Review 3.  Radiation treatment for rectal cancer.

Authors:  B J Cummings
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer.

Authors:  Sun Hyun Bae; Won Park; Doo Ho Choi; Heerim Nam; Won Ki Kang; Young Suk Park; Joon Oh Park; Ho Kyung Chun; Woo Yong Lee; Seong Hyeon Yun; Hee Cheol Kim
Journal:  Radiat Oncol       Date:  2011-05-21       Impact factor: 3.481

5.  [Results of the treatment with fast neutrons (d.T 13 MeV) in recurrent rectal carcinoma].

Authors:  F J Prott; R Pötter; P Preusser; O Micke; A Schouwink; N Willich
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

Review 6.  Bringing the heavy: carbon ion therapy in the radiobiological and clinical context.

Authors:  Cody D Schlaff; Andra Krauze; Arnaud Belard; John J O'Connell; Kevin A Camphausen
Journal:  Radiat Oncol       Date:  2014-03-28       Impact factor: 3.481

Review 7.  ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer.

Authors:  Felipe A Calvo; Claudio V Sole; Harm J Rutten; Wim J Dries; Miguel A Lozano; Mauricio Cambeiro; Philip Poortmans; Luis González-Bayón
Journal:  Clin Transl Radiat Oncol       Date:  2020-06-17

8.  Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801).

Authors:  Shintaro Shiba; Masahiko Okamoto; Hiroki Kiyohara; Tatsuya Ohno; Takuya Kaminuma; Takayuki Asao; Hitoshi Ojima; Ken Shirabe; Hiroyuki Kuwano; Takashi Nakano
Journal:  Front Oncol       Date:  2019-07-31       Impact factor: 6.244

Review 9.  A review of update clinical results of carbon ion radiotherapy.

Authors:  Hirohiko Tsujii; Tadashi Kamada
Journal:  Jpn J Clin Oncol       Date:  2012-07-13       Impact factor: 3.019

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.